Global Gamma Knife Market Value and Market Share Analysis

Date: 2016-03-28

There are five major types of Gamma Knife indications:  Brain Metastasis, Cancer, Arteriovenous Malformation (AVM), Trigeminal Neuralgia and Others. Brain Metastasis treatment contribute around 68.5% share of the global Gamma Knife value in 2014, Brain Metastasis is anticipated to witness a CAGR of 9.2% during the forecast period.

Brain metastasis accounts for the major share of the global Gamma Knife market. This segment was valued at US$ 108.7 Million in 2014 and expects it to expand at a Y-o-Y rate of 8.7% to reach a valuation of US$ 118.2 Million by the end of 2015. By the end of 2025, anticipates the brain metastasis segment to reach a valuation of US$ 285.7 Million.

Cancer is the second-largest indication segment with a share of 10.2% of the global Gamma Knife market. We anticipate this segment to expand at a CAGR of 10.3% during the forecast period.

AVM, Trigeminal Neuralgia and others segments (pituitary tumour, epilepsy, acoustic neuroma and Parkinson’s disease) collectively contributed 21.2% share to the overall Gamma Knife market in 2014.

Considering the type of body part treated with Gamma Knife, the global Gamma Knife market is segmented into: Head, Neck and Other body parts. Among the aforementioned segments, Head treatment with Gamma Knife is expected to dominate the global market with over 88.1% market value share throughout the forecast period. The global head treatment with Gamma Knife accounted for US$ 139.8 Million in 2014, and is anticipated to reach a value of US$ 364.8 Million by 2025, growing at a CAGR of 9.2% during the forecast period. Moreover, the scope of Gamma Knife treatment in other indications is expected to expand in the future too, due to market expansion and innovation in techniques.

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample